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INTRODUCTION
Organophosphorus pesticides (OPs) are widely 
used in agriculture as insecticides, fungicides and ro-
denticides. They have a specific unpleasant odor. Due 
to their widespread use and high lethality, intoxica-
tions with them are a global problem (1,2). More than 
200,000 people die each year after poisoning with 
OPs (3). Patients with acute organophosphorus in-
toxications require immediate treatment to prevent 
complications and lethal outcome. Despite the con-
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temporary treatment approaches, lethality after poi-
soning with OPs is 20-30% (4). Most OPs have very 
high solubility in lipids. After identifying the anti-
dote properties of intravenous lipid emulsion (ILE) 
and adopting regulations about its use for the treat-
ment of local anesthetics causing systemic toxici-
ty (5,6), it has also been adopted in the treatment of 
acute intoxications with other lipophilic xenobiotics. 
Its healing effect had been mainly demonstrated in 
acute poisonings with antidepressants, neuroleptics, 
calcium antagonists and beta blockers (7,8).
CASE REPORT 
A 64-year-old man was admitted for treatment 
to the Clinic of Toxicology at the Military Medical 
Academy Hospital - Varna on 16 June, 2017, 24 hours 
after swallowing of 50 ml of fenitrothion. Shortly af-
ter hospitalization, he started vomiting. A tachycar-
dia with a heart rate of 110 beats/min and high blood 
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pressure values of 220/120 mmHg were detected by 
the doctor in the ambulatory. 
The patient refused hospitalization. After gas-
tric lavage and overcoming the hypertonic crisis, 
he was released from the hospital. Ten hours after 
the ingestion of the pesticide, a pronounced asthe-
nia-adynamia occurred to an extent that the patient 
could not stand up alone from the bed without assis-
tance, he got dyspnea and myofibrillations. On the 
23rd hour he was examined again by a doctor at home. 
Hypersalivation, abundant sweating, 100/60 mmHg 
arterial pressure, and increased breathing rate were 
established. After administration of atropine the pa-
tient was directed to a stationary treatment.
Upon admission to the hospital, depressed con-
sciousness according to Glasgow Coma Scale (GCS) - 
8, tachypnea 30 breaths/min, heart rate 65 beats/min 
and blood pressure 140/80 mmHg were recorded. 
The pupils of the eyes were myotic with faint (slowed 
down) response to light, decreased muscle tonus and 
typical pungent smell of OPs were detected. Anoth-
er gastric lavage was performed, atrophy was regis-
tered, a treatment with atropine, toxogonin, intra-
venous infusions of saline, 5% glucose, ringer-lac-
tate, diazepam, and ceftriaxone was initiated. In the 
following days, the dose of atropine was titrated ac-
cording to the clinical response and symptoms of 
atropinization.
Tracked in dynamics laboratory indices dem-
onstrated mild renal and hepatic impairment, also 
indicated by the low pseudocholinesterase (PChE) 
levels (Table 1).
Upon admission to the hospital, the patient was 
with acute respiratory failure (Table 2).
Chest roentgenography indicated pulmonary 
arrest. On the electrocardiogram a sinus rhythm 
with a frequency of 68 beats/min and an indifferent 
electric position were recorded.  
On the following days normal values from the 
blood and gas analyses were established, the only ex-
ception being PChE laboratory tests and the slight-
ly elevated aspartate aminotransferase (ASAT) and 
gamma-glutamyl transferase (GGT) values. The oth-
er vital indicators were also stabilized - blood pres-
sure, heart rate, and respiration. The patient was dis-
charged from the hospital on the 10th day of his stay 
in a good overall state. 
DISCUSSION 
Organophosphorus intoxication develops in 
three phases (9,10): acute cholinergic phase, interme-
dia syndrome, and late polyneuropathy. 
The clinical picture includes symptoms of a 
number of body organs and systems that develop af-
ter a short latency period - from a few minutes to 1-2 
hours:
 Gastrointestinal tract - nausea, vomiting, ab-
dominal pain, diarrhea;
Laboratory indices 1st day 2nd day 3rd day 7th day 10th day
PChE (U/l) 1500 1300 1100 1400 2200
Urea  (mmol/l) 10.7 13.7 - 8.3 7.4
Creatinine (mkmol/l) 170.8 191.9 75.1 69 -
Creatine phosphokinase (U/l) 378.2 341.3 - 54.7 -
ASAT (U/l) 19 - - 30.1 -
ALAT (U/l) 22.8 - - 78 -
GGT (U/l) 43.9 - - 106 -
Table 1. Laboratory findings in the course of the treatment of a patient with OPs poisoning (PChE, pseudo cholinester-
ase; ASAT, aspartate aminotransferase; ALAT, alanine aminotransferase; GGT, gamma glutamyl transferase; -, not 
measured) 
Laboratory indices 1st day 3rd day
рН 7.31 7.44
pO2 (kPa) 3.6 8.1
pCO2 (kPa) 6.5 4,6
HCO3 (mmol/l) 24 28
Oxygen saturation (percentages) 44 92
Table 2. Blood gas analysis findings in the course of the 
treatment of a patient with OPs poisoning
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 Nervous system - myosis, sweating, intoxication 
psychoses, quantifiable changes in conscious-
ness up to coma, myofibrillations, convulsions; 
 Respiratory system - obturation-aspiration dis-
orders due to bronchorrhea and bronchospasm, 
pulmonary edema, pneumonia, respiratory 
muscles paralysis;
 Cardiovascular system - early hypertonic syn-
drome, rhythm and conduction disorders, exo-
toxic shock;
 Liver and kidney manifestations - manifesta-
tions of toxic hepatitis with prevalence of non-
icterus forms and renal impairment to acute 
renal failure (ARF). More often, non-oliguric 
forms of ARF develop.
 Multiple organ syndrome failure - develops 
very often in acute intoxications with OPs.
The available anamnestic data and the ob-
served clinical symptoms have made it easier to di-
agnose our patient. The diagnosis was confirmed by 
the low PChE values. Tachycardia detected at first 
examination and high blood pressure resulted from 
the predominance of nicotine over muscarinic ef-
fects at the onset of intoxication. After the hospital-
ization of the patient, therapy standard for organo-
phosphorus intoxication was undertaken. Due to the 
late arrival at the hospital and the developed clini-
cal picture with dominating neurological symptoms, 
ILE was administered 3 hours after admission to the 
hospital. Fenitrothion is practically insoluble in wa-
ter but it is well soluble in organic solvents. In recent 
years, ILE has been successfully applied to poison-
ing with various lipophilic xenobiotics, and not only 
to control local anesthetics-caused systemic toxicity 
(LAST). It removes not only cardiotoxic but also neu-
rological manifestations (11). The therapeutic effect 
of ILE in organophosphorus poisonings has been de-
scribed for the first time for acute parathion intoxica-
tion (12). A number of authors recommend ILE as a 
new potential method for the treatment of severe or-
ganophosphorus intoxications (13,14,15). The main 
mechanism of action of ILE is the so-called “lipid 
sink” phenomenon. The rapid administration of a 
lipid emulsion as a bolus dose creates a new, extend-
ed lipid phase that absorbs lipophilic xenobiotics (16) 
and prevents their binding to the corresponding re-
ceptors. Decreased serum concentration of the xeno-
biotic leads to its extraction from tissues and reduced 
toxicity (17). ILE increases intracellular fatty acids 
and restores the synthesis of adenosine triphosphate 
in myocardial cells, improving myocardial contrac-
tility. The lipid emulsion increases the concentration 
of intracellular calcium, resulting in a direct posi-
tive inotropic effect. ILE was administered as a bolus 
dose of 1.5 ml/kg Intralipid 20% followed by intrave-
nous infusion at a rate of 0.25 ml/kg/min. The total 
dose of lipid emulsion administered was 1000 ml. On 
the 16th hour of the hospitalization, the patient re-
covered clear consciousness - GCS - 15. No side ef-
fects related to the administration of the lipid emul-
sion were observed.
CONCLUSION
Most OPs are liposoluble. In the case of severe 
organophosphorus intoxication, ILE could contrib-
ute to their successful treatment and reduction of le-
thality rate. This method is recommended in addi-
tion to the established in clinical practice treatment.
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